Cargando…
Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers
Epigenetic modifiers acting through polypharmacology mechanisms are promising compounds with which to treat several infectious diseases. Histone deacetylase (HDAC) enzymes, mainly class I, and extra-terminal bromodomains (BET) are involved in viral replication and the host response. In the present s...
Autores principales: | Lopes, Juliana Romano, Prokopczyk, Igor Muccilo, Gerlack, Max, Man Chin, Chung, Santos, Jean Leandro Dos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709175/ https://www.ncbi.nlm.nih.gov/pubmed/34959707 http://dx.doi.org/10.3390/ph14121308 |
Ejemplares similares
-
Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity
por: Clementino, Leandro da Costa, et al.
Publicado: (2021) -
Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
por: Urias, Beatriz Silva, et al.
Publicado: (2022) -
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds †
por: Fernandes, Guilherme Felipe dos Santos, et al.
Publicado: (2017) -
Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease
por: Pavan, Aline Renata, et al.
Publicado: (2022) -
Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach
por: Bosquesi, Priscila Longhin, et al.
Publicado: (2011)